Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

Simian adenoviral and modified vaccinia Ankara (MVA) viral vectors used in heterologous prime-boost strategies are potent inducers of T cells against encoded antigens and are in advanced testing as vaccine carriers for a wide range of infectious agents and cancers. It is unclear if these responses c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:NPJ Vaccines
Main Authors: Capone, Stefania, Brown, Anthony, Hartnell, Felicity, Sorbo, Mariarosaria Del, Traboni, Cinzia, Vassilev, Ventzislav, Colloca, Stefano, Nicosia, Alfredo, Cortese, Riccardo, Folgori, Antonella, Klenerman, Paul, Barnes, Eleanor, Swadling, Leo
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7550607/
https://ncbi.nlm.nih.gov/pubmed/33083029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-020-00240-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares